These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20628127)

  • 1. Bias and trials stopped early for benefit.
    Ellenberg SS; DeMets DL; Fleming TR
    JAMA; 2010 Jul; 304(2):158; author reply 158-9. PubMed ID: 20628127
    [No Abstract]   [Full Text] [Related]  

  • 2. Bias and trials stopped early for benefit.
    Berry SM; Carlin BP; Connor J
    JAMA; 2010 Jul; 304(2):156; author reply 158-9. PubMed ID: 20628124
    [No Abstract]   [Full Text] [Related]  

  • 3. Bias and trials stopped early for benefit.
    Goodman S; Berry D; Wittes J
    JAMA; 2010 Jul; 304(2):157; author reply 158-9. PubMed ID: 20628126
    [No Abstract]   [Full Text] [Related]  

  • 4. Bias and trials stopped early for benefit.
    Korn EL; Freidlin B; Mooney M
    JAMA; 2010 Jul; 304(2):157-8; author reply 158-9. PubMed ID: 20628125
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimizing bias in randomized trials: the importance of blinding.
    Psaty BM; Prentice RL
    JAMA; 2010 Aug; 304(7):793-4. PubMed ID: 20716744
    [No Abstract]   [Full Text] [Related]  

  • 6. Importance of blinding in randomized trials.
    Strite SA; Stuart ME
    JAMA; 2010 Nov; 304(19):2127-8; author reply 2128. PubMed ID: 21081725
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing the effects of bias on the magnitude of outcomes in clinical studies: lessons for the research community?
    Hughes FJ
    J Clin Periodontol; 2008 Sep; 35(9):773-4. PubMed ID: 18840152
    [No Abstract]   [Full Text] [Related]  

  • 8. Systematic reviews are not biased by results from trials stopped early for benefit.
    Goodman SN
    J Clin Epidemiol; 2008 Jan; 61(1):95-6; author reply 96-8. PubMed ID: 18083466
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessing risk of bias in randomized controlled trials.
    Purgato M; Barbui C; Cipriani A
    Epidemiol Psichiatr Soc; 2010; 19(4):296-7. PubMed ID: 21322502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between unreported outcomes and effect size estimates in Cochrane meta-analyses.
    Furukawa TA; Watanabe N; Omori IM; Montori VM; Guyatt GH
    JAMA; 2007 Feb; 297(5):468-70. PubMed ID: 17284696
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of randomized controlled trials: issues to consider when designing a trial.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2013 Jun; 143(6):905-7. PubMed ID: 23726342
    [No Abstract]   [Full Text] [Related]  

  • 12. Sources of bias in clinical trials.
    Pandis N
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):595-6. PubMed ID: 21967950
    [No Abstract]   [Full Text] [Related]  

  • 13. Assuring that double-blind is blind.
    Perlis RH; Ostacher M; Fava M; Nierenberg AA; Sachs GS; Rosenbaum JF
    Am J Psychiatry; 2010 Mar; 167(3):250-2. PubMed ID: 20194487
    [No Abstract]   [Full Text] [Related]  

  • 14. Eligibility criteria of randomized controlled trials.
    Costantino G; Ceriani E; Rusconi AM; Montano N
    JAMA; 2007 Jul; 298(1):39; author reply 39-40. PubMed ID: 17609487
    [No Abstract]   [Full Text] [Related]  

  • 15. Stopping trials for efficacy: an almost unbiased view.
    Goodman SN
    Clin Trials; 2009 Apr; 6(2):133-5. PubMed ID: 19342465
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular genetics: what's left for clinicians?
    Whisnant JP
    J Child Neurol; 1994 Oct; 9(4):349-51. PubMed ID: 7822722
    [No Abstract]   [Full Text] [Related]  

  • 17. The Heart Protection Study and bias in the interpretation of RCTs.
    Conradi P; Taylor D
    J Eval Clin Pract; 2005 Aug; 11(4):405-7. PubMed ID: 16011653
    [No Abstract]   [Full Text] [Related]  

  • 18. Are placebo-controlled studies required in order to prove efficacy of antidepressants?
    Möller HJ
    World J Biol Psychiatry; 2005; 6(3):130-1. PubMed ID: 16166027
    [No Abstract]   [Full Text] [Related]  

  • 19. Sample size determination and statistical power in randomized controlled trials.
    Sjögren P; Hedström L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):652-3. PubMed ID: 20416528
    [No Abstract]   [Full Text] [Related]  

  • 20. Author's reply. Comments on 'On estimating treatment effects under non-compliance in randomized clinical trials: are intent-to-treat or instrumental variables analyses perfect solutions?' by Heejung Bang and Clarence E. Davis, Statistics in Medicine 2007; 26:954-964.
    Bang H; Davis CE
    Stat Med; 2009 Jun; 28(14):1967-8. PubMed ID: 19489015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.